| Title | Therapeutic Advances in Psychopharmacology |
| Abbreviation | Ther. Adv. Psychopharmacol. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1) |
| h-index | 43 |
| Overall Rank/Ranking | 3396 |
| SCImago Journal Rank (SJR) | 1.179 |
| Impact Score | 3.45 |
| Publisher | SAGE Publications Inc. |
| Country | United States |
| ISSN | 20451261, 20451253 |
| Best Quartile | Q1 |
| Coverage History | 2011-2015 |
Therapeutic Advances in Psychopharmacology is a journal covering the technologies/fields/categories related to Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1). It is published by SAGE Publications Inc.. The overall rank of Therapeutic Advances in Psychopharmacology is 3396. According to SCImago Journal Rank (SJR), this journal is ranked 1.179. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 43. The best quartile for this journal is Q1.
The ISSN of Therapeutic Advances in Psychopharmacology journal is 20451261, 20451253. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Therapeutic Advances in Psychopharmacology is cited by a total of 624 articles during the last 3 years (Preceding 2023).
The Impact IF 2023 of Therapeutic Advances in Psychopharmacology is 3.45, which is computed in 2024 as per its definition. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2023 of Therapeutic Advances in Psychopharmacology is 3.45. If the same upward trend persists, Impact IF may rise in 2024 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 3.45 |
| 2015 | 2.01 |
| 2014 | 1.32 |
Therapeutic Advances in Psychopharmacology has an h-index of 43. It means 43 articles of this journal have more than 43 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Therapeutic Advances in Psychopharmacology is 20451261, 20451253. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Therapeutic Advances in Psychopharmacology is 3396. According to SCImago Journal Rank (SJR), this journal is ranked 1.179. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 1.179 |
| 2015 | |
| 2014 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 3396 |
| 2015 | 33695 |
| 2014 | 32957 |
Therapeutic Advances in Psychopharmacology is published by SAGE Publications Inc.. It's publishing house is located in United States. Coverage history of this journal is as following: 2011-2015. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Therapeutic Advances in Psychopharmacology is Ther. Adv. Psychopharmacol.. This abbreviation ('Ther. Adv. Psychopharmacol.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Therapeutic Advances in Psychopharmacology latest impact IF is 3.45. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this journal are 3.45 (2023) and 1.32 (2014), respectively, in the last 3 years. Moreover, its average IS is 2.26 in the previous 3 years.
The Therapeutic Advances in Psychopharmacology has an SJR (SCImago Journal Rank) of 1.179, according to the latest data. It is computed in the year 2024. In the past 3 years, this journal has recorded a range of SJR, with the highest being 1.179 in 2023 and the lowest being in 2015. Furthermore, the average SJR of the Therapeutic Advances in Psychopharmacology over the previous 3-year period stands at 2.26.
The latest h-index of the Therapeutic Advances in Psychopharmacology is 43.
The Therapeutic Advances in Psychopharmacology is published by the SAGE Publications Inc., with its country of publication being the United States.
The Therapeutic Advances in Psychopharmacology is currently ranked 3396 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 3 years, this journal has experienced varying rankings, reaching its highest position of 3396 in 2023 and its lowest position of 33695 in 2015.
The standard ISO4 abbreviation for the Therapeutic Advances in Psychopharmacology is Ther. Adv. Psychopharmacol..
Therapeutic Advances in Psychopharmacology is classified as a journal that the SAGE Publications Inc. publishes.
The Therapeutic Advances in Psychopharmacology encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Therapeutic Advances in Psychopharmacology is assigned the following International Standard Serial Numbers (ISSN): 20451261, 20451253.
The best quartile for the Therapeutic Advances in Psychopharmacology is Q1 (2023).
The Therapeutic Advances in Psychopharmacology coverage history can be summarized as follows: 2011-2015.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Indian Journal of Plastic Surgery | journal | 13847 | Thieme Medical Publishers, Inc. | 40 | 0.59 |
| Milan Journal of Mathematics | journal | 3538 | Birkhauser Verlag Basel | 29 | 1.14 |
| Journal of Business Finance and Accounting | journal | 2938 | Wiley-Blackwell Publishing Ltd | 91 | 3.64 |
| Journal of Supply Chain Management | journal | 587 | Wiley-Blackwell | 112 | 12.51 |
| Entrepreneurship Theory and Practice | journal | 220 | Wiley-Blackwell | 198 | 15.69 |
| Howard Journal of Communications | journal | 10151 | Taylor and Francis Ltd. | 39 | 1.66 |
| Proceedings of the International Semiconductor Conference, CAS | conference and proceedings | 25734 | Institute of Electrical and Electronics Engineers Inc. | 16 | 0.00 |
| Biological Procedures Online | journal | 4092 | BioMed Central Ltd | 48 | 3.54 |
| Epigenetics | journal | 3529 | Landes Bioscience | 111 | 3.22 |
| Rudarsko Geolosko Naftni Zbornik | journal | 13873 | 19 | 1.48 |
| Year | Impact Score (IS) |
|---|---|
| 2024/2025 | Coming Soon |
| 2023 | 3.45 |
| 2015 | 2.01 |
| 2014 | 1.32 |
